Explore our thoughts and insights on learning science and the education space.
November 19, 2026; By Amy Badovick
This article outlines the questions to settle before your 2027 L&D plan is final, practical ways to get more from a flat budget, and the Medical Affairs, Commercial, and Market Access trends that should shape program design in 2027.
September 10, 2026; By ERS Team
Real-world evidence (RWE) and health economics and outcomes research (HEOR) have become standard inputs into payer decisions, yet most Market Access field training still centers on the clinical dossier.
July 28, 2026; By ERS Team
Traditional training metrics may show that MSLs know the science, but they do not reveal whether they can turn that knowledge into meaningful scientific exchanges, influence KOLs, and generate actionable insights.
June 11, 2026; By ERS Team
In today’s commercial pharmaceutical environment, physician access is no longer guaranteed and time is the most constrained commodity of all.
June 10, 2026; By ERS Team
Differentiation is one of the most persistent challenges facing today’s pharmaceutical field teams.
The Galleria
2 Bridge Avenue, #632
Red Bank, New Jersey 07701
Email: lifesciences@educationalresource.com